Åsa K. Wallin

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser, Frans R.J. Verhey, Dirk L. Knol et al. · The Lancet Neurology · 2009 · 617 citations

Neuropsychology, Alzheimer's Disease, Psychiatry +8

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and <i>APOE</i> genotype

Lisa Vermunt, Sietske A.M. Sikkes, Ardo van den Hout et al. · Alzheimer s & Dementia · 2019 · 535 citations · Full text

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

Paweł Baranczewski, Andrzej Stańczak, Kathrin Sundberg et al. · PubMed · 2007 · 290 citations

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

Ingrid S. van Maurik, Stephanie J. B. Vos, Isabelle Bos et al. · The Lancet Neurology · 2019 · 144 citations · Full text

An Arctic Ocean ice shelf during MIS 6 constrained by new geophysical and geological data

Martin Jakobsson, Johan Nilsson, Matt O’Regan et al. · Quaternary Science Reviews · 2010 · 133 citations · Full text

Geophysics, Marine Geology, Arctic Science +14